Skip to main content
Top
Published in: Inflammation 2/2008

01-04-2008

A Comparative Study of Interleukin-1β Production and P2x7 Expression After Atp Stimulation by Peripheral Blood Mononuclear Cells Isolated From Rheumatoid Arthritis Patients and Normal Healthy Controls

Authors: Ahmed Al-Shukaili, Juma Al-Kaabi, Batool Hassan

Published in: Inflammation | Issue 2/2008

Login to get access

Abstract

Interleukin 1 beta (IL-1β) is a proinflammatory cytokine that is considered to play an important role in the progression of rheumatoid arthritis (RA). A stimulus such as ATP is necessary to cause the release of mature IL-1β, via activation of the P2X7 receptor on monocytes. In this study, the production of IL-1β in whole blood after ATP stimulation and expression of P2X7 receptors in RA and healthy subjects were examined. Blood samples from RA patients or healthy controls were stimulated with ATP in the presence of lipopolysaccharide (LPS). Supernatants were harvested and IL-1β levels were measured by enzyme-linked immunosorbent assay (ELISA). Expression of P2X7 receptors was measured using flow cytometry. ATP induced significantly higher levels of IL-1β in LPS-activated RA blood samples compared to controls. A significant up-regulation of P2X7 receptor expression on mononuclear cells was observed after overnight incubation with ATP without any significant differences between RA patients and normals. These data suggest that RA patient mononuclear cells are more sensitive to ATP stimulation than healthy individuals perhaps due to genetic polymorphism in the P2X7 gene.
Literature
1.
go back to reference Alamanos, Y., P. Voulgari, and A. Drosos. 2006. Incidence and prevalence of rheumatoid Arthritis, based on the 1987 American College of Rheumatology Criteria: a systematic review. Semin. Arthritis. Rheum. 36:182–188.PubMedCrossRef Alamanos, Y., P. Voulgari, and A. Drosos. 2006. Incidence and prevalence of rheumatoid Arthritis, based on the 1987 American College of Rheumatology Criteria: a systematic review. Semin. Arthritis. Rheum. 36:182–188.PubMedCrossRef
2.
go back to reference Sewell, K., and D. E. Trentham. 1993. Pathogenesis of rheumatoid arthritis. Lancet 34:283–286.CrossRef Sewell, K., and D. E. Trentham. 1993. Pathogenesis of rheumatoid arthritis. Lancet 34:283–286.CrossRef
3.
go back to reference Dinarello, C. A.. 1996. Biological basis for interleukin-1 in disease. Blood 87:2095–2147.PubMed Dinarello, C. A.. 1996. Biological basis for interleukin-1 in disease. Blood 87:2095–2147.PubMed
4.
go back to reference Kostura, M. J., M. J. Tocci, G. Limjuco, J. Chin, P. Cameron, A. G. Hillman, N. A. Chartrain, and J. A. Schmidt. 1989. Identification of a monocytes specific pre-interleukin-1 convertase activity. Proc. Natl. Acad. Sci. USA 86:5227–5231.PubMedCrossRef Kostura, M. J., M. J. Tocci, G. Limjuco, J. Chin, P. Cameron, A. G. Hillman, N. A. Chartrain, and J. A. Schmidt. 1989. Identification of a monocytes specific pre-interleukin-1 convertase activity. Proc. Natl. Acad. Sci. USA 86:5227–5231.PubMedCrossRef
5.
go back to reference Ferrari, D., M. Villalba, P. Chiozzi, S. Falzoni, P. Ricciardi-Castagnoli, and F. Di Virgilio. 1996. Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. J. Immunol. 156:1531–1539.PubMed Ferrari, D., M. Villalba, P. Chiozzi, S. Falzoni, P. Ricciardi-Castagnoli, and F. Di Virgilio. 1996. Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. J. Immunol. 156:1531–1539.PubMed
6.
go back to reference Ferrari, D., P. Chiozzi, S. Falzoni, M. Dal Susino, L. Melchiorri, O. R. Baricordi, and F. Di Virgilio. 1997. Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J. Immunol. 159:1451–1458.PubMed Ferrari, D., P. Chiozzi, S. Falzoni, M. Dal Susino, L. Melchiorri, O. R. Baricordi, and F. Di Virgilio. 1997. Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J. Immunol. 159:1451–1458.PubMed
7.
go back to reference Perregaux, D. G., and C. A. Gabel. 1998. Post-translational processing of murine IL-1: evidence that ATP-induced release of IL-1 alpha and IL-1 beta occurs via a similar mechanism. J. Immunol. 160:2469–2477.PubMed Perregaux, D. G., and C. A. Gabel. 1998. Post-translational processing of murine IL-1: evidence that ATP-induced release of IL-1 alpha and IL-1 beta occurs via a similar mechanism. J. Immunol. 160:2469–2477.PubMed
8.
go back to reference Laliberte, R., J. Eggler, and C. A. Gabel. 1999. ATP treatment of human monocytes promotes caspase-1 maturation and externalization. J. Biol. Chem. 274:36944–36951.PubMedCrossRef Laliberte, R., J. Eggler, and C. A. Gabel. 1999. ATP treatment of human monocytes promotes caspase-1 maturation and externalization. J. Biol. Chem. 274:36944–36951.PubMedCrossRef
9.
go back to reference Perregaux, D. G., P. McNiff, R. Laliberte, M. Conklyn, and C. A. Gabel. 2000. ATP acts as an agonist to promote stimulus-induced secretion of IL-1 beta and IL-18 in human blood. J. Immunol. 165:4615–4623.PubMed Perregaux, D. G., P. McNiff, R. Laliberte, M. Conklyn, and C. A. Gabel. 2000. ATP acts as an agonist to promote stimulus-induced secretion of IL-1 beta and IL-18 in human blood. J. Immunol. 165:4615–4623.PubMed
10.
go back to reference Mehta, V. B., J. Hart, and M. D. Wewers. 2001. ATP-stimulated release of interleukin (IL)-1β and IL-18 requires priming by lipopolysaccharide and is independent of caspase-1 cleavage. J. Biol. Chem. 276:3820–3826.PubMedCrossRef Mehta, V. B., J. Hart, and M. D. Wewers. 2001. ATP-stimulated release of interleukin (IL)-1β and IL-18 requires priming by lipopolysaccharide and is independent of caspase-1 cleavage. J. Biol. Chem. 276:3820–3826.PubMedCrossRef
11.
go back to reference Ferrari, D., C. Pizzirani, E. Adinolfi, R. M. Lemoli, A. Curti, M. Idzko, E. Panther, and F. Di Virgilio. 2006. The P2X7 receptor: a key player in IL-1 processing and release. J. Immunol. 176:3877–3883.PubMed Ferrari, D., C. Pizzirani, E. Adinolfi, R. M. Lemoli, A. Curti, M. Idzko, E. Panther, and F. Di Virgilio. 2006. The P2X7 receptor: a key player in IL-1 processing and release. J. Immunol. 176:3877–3883.PubMed
12.
go back to reference Gu, B. J., W. Y. Zhang, L. J. Bendall, I. P. Chessell, G. N. Buell, and J. S. Wiley. 2000. Expression of P2X7 purinoceptors on human lymphocytes and monocyes: Evidence for non-functional P2X7 receptors. Am. J. Physiol. 279:C1189–C1197. Gu, B. J., W. Y. Zhang, L. J. Bendall, I. P. Chessell, G. N. Buell, and J. S. Wiley. 2000. Expression of P2X7 purinoceptors on human lymphocytes and monocyes: Evidence for non-functional P2X7 receptors. Am. J. Physiol. 279:C1189–C1197.
13.
go back to reference Wiley, J. S., C. E. Gargett, W. Zhang, M. B. Snook, and G. P. Jamieson. 1998. Partial agonists and antagonists reveal a second permeability state of human lymphocyte P2Z/P2X7 channel. Am. J. Physiol. 275:C1224–C1231.PubMed Wiley, J. S., C. E. Gargett, W. Zhang, M. B. Snook, and G. P. Jamieson. 1998. Partial agonists and antagonists reveal a second permeability state of human lymphocyte P2Z/P2X7 channel. Am. J. Physiol. 275:C1224–C1231.PubMed
14.
go back to reference Wilson, H., S. Francis, S. Dower, and D. Corssman. 2004. Secretion of intracellular IL-1 receptor antagonist (type 1) is dependent on P2X7 receptor activation. J. Immunol. 173:1202–1208.PubMed Wilson, H., S. Francis, S. Dower, and D. Corssman. 2004. Secretion of intracellular IL-1 receptor antagonist (type 1) is dependent on P2X7 receptor activation. J. Immunol. 173:1202–1208.PubMed
15.
go back to reference Arnett, F. C., S. M. Edworthy, D. A. Bloch, D. J. McShane, J. F. Fries, N. S. Cooper, L. A. Healey, S. R. Kaplan, M. H. Liang, H. S. Luthra et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31:315–324.PubMedCrossRef Arnett, F. C., S. M. Edworthy, D. A. Bloch, D. J. McShane, J. F. Fries, N. S. Cooper, L. A. Healey, S. R. Kaplan, M. H. Liang, H. S. Luthra et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31:315–324.PubMedCrossRef
16.
go back to reference Sluyter, R., A. N. Shemon, and J. S. Wiley. 2004. Glu496 to Ala polymorphism in the P2X7 receptor impairs ATP-induced IL-1 beta release from human monocytes. J. Immunol. 172:3399–3405.PubMed Sluyter, R., A. N. Shemon, and J. S. Wiley. 2004. Glu496 to Ala polymorphism in the P2X7 receptor impairs ATP-induced IL-1 beta release from human monocytes. J. Immunol. 172:3399–3405.PubMed
17.
go back to reference Franco-Martinez, S., P. Nino-Moreno, S. Bernal-Silva, L. Baranda, M. Rocha-Meza, L. Portales-Cervantes, E. Layseca-Espinosa, R. Gonzalez-Amaro, and D. Portales-Perez. 2006. Expression and function of the purinergic receptor P2X7 in patients with pulmonary tuberculosis. Clin. Exp. Immunol. 46:253–261.CrossRef Franco-Martinez, S., P. Nino-Moreno, S. Bernal-Silva, L. Baranda, M. Rocha-Meza, L. Portales-Cervantes, E. Layseca-Espinosa, R. Gonzalez-Amaro, and D. Portales-Perez. 2006. Expression and function of the purinergic receptor P2X7 in patients with pulmonary tuberculosis. Clin. Exp. Immunol. 46:253–261.CrossRef
18.
go back to reference Wiley, J. S., L. P. Dao-Ung, B. J. Gu, R. Sluyter, A. N. Shemon, C. Li, J. Taper, J. Gallo, and A. Manoharan. 2002. A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study. Lancet 359:1114–1119.PubMedCrossRef Wiley, J. S., L. P. Dao-Ung, B. J. Gu, R. Sluyter, A. N. Shemon, C. Li, J. Taper, J. Gallo, and A. Manoharan. 2002. A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study. Lancet 359:1114–1119.PubMedCrossRef
19.
go back to reference Gu, B. J., W. Zhang, R. A. Worthington, R. Sluyter, P. Dao-Ung, S. Petrou, J. A. Barden, and J. S. Wiley. 2001. A Glu-496 to Ala polymorphism leads to loss of function of the human P2X7 receptor. J. Biol. Chem. 276:11135–11142.PubMedCrossRef Gu, B. J., W. Zhang, R. A. Worthington, R. Sluyter, P. Dao-Ung, S. Petrou, J. A. Barden, and J. S. Wiley. 2001. A Glu-496 to Ala polymorphism leads to loss of function of the human P2X7 receptor. J. Biol. Chem. 276:11135–11142.PubMedCrossRef
20.
go back to reference Gu, B. J., R. Sluyter, K. K. Skarratt, A. N. Shemon, L. P. Dao-Ung, S. J. Fuller, J. A. Barden, A. L. Clarke, S. Petrou, and J. S. Wiley. 2004. An Arg307 to Gln polymorphism within the ATP-binding site causes loss of function of the human P2X7 receptor. J. Biol. Chem. 279:31287–31295.PubMedCrossRef Gu, B. J., R. Sluyter, K. K. Skarratt, A. N. Shemon, L. P. Dao-Ung, S. J. Fuller, J. A. Barden, A. L. Clarke, S. Petrou, and J. S. Wiley. 2004. An Arg307 to Gln polymorphism within the ATP-binding site causes loss of function of the human P2X7 receptor. J. Biol. Chem. 279:31287–31295.PubMedCrossRef
21.
go back to reference Skarratt, K. K., S. J. Fuller, R. Sluyter, L. P. Dao-Ung, B. J. Gu, and J. S. Wiley. 2005. A 5′ intronic splice site polymorphism leads to a null allele of the P2X7 gene in 1–2% of the Caucasian population. FEBS Lett. 579:2675–2678.PubMedCrossRef Skarratt, K. K., S. J. Fuller, R. Sluyter, L. P. Dao-Ung, B. J. Gu, and J. S. Wiley. 2005. A 5′ intronic splice site polymorphism leads to a null allele of the P2X7 gene in 1–2% of the Caucasian population. FEBS Lett. 579:2675–2678.PubMedCrossRef
22.
go back to reference Cabrini, G., S. Falzoni, S. L. Forchap, P. Pellegatti, A. Balboni, P. Agostini, A. Cuneo, G. Castoldi, O. R. Baricordi, and F. Di Virgilio. 2005. A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. J. Immunol. 175:82–89.PubMed Cabrini, G., S. Falzoni, S. L. Forchap, P. Pellegatti, A. Balboni, P. Agostini, A. Cuneo, G. Castoldi, O. R. Baricordi, and F. Di Virgilio. 2005. A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. J. Immunol. 175:82–89.PubMed
23.
go back to reference Saunders, B. M., S. L. Fernando, R. Sluyter, W. J. Britton, and J. S. Wiley. 2003. A loss of function polymorphism in the human P2X7 receptor abolishes ATP-mediated killing of mycobacteria. J. Immunol. 171:5442–5446.PubMed Saunders, B. M., S. L. Fernando, R. Sluyter, W. J. Britton, and J. S. Wiley. 2003. A loss of function polymorphism in the human P2X7 receptor abolishes ATP-mediated killing of mycobacteria. J. Immunol. 171:5442–5446.PubMed
24.
go back to reference Fernando, S. L., B. M. Saunders, R. Sluyter, K. K. Skarratt, J. S. Wiley, and W. J. Britton. 2005. Gene dosage determines the negative effect of polymorphic alleles of the P2X7 receptor on adenosine triphosphate-mediated killing of mycobacteria by human macrophages. J. Infect. Dis. 192:149–155.PubMedCrossRef Fernando, S. L., B. M. Saunders, R. Sluyter, K. K. Skarratt, J. S. Wiley, and W. J. Britton. 2005. Gene dosage determines the negative effect of polymorphic alleles of the P2X7 receptor on adenosine triphosphate-mediated killing of mycobacteria by human macrophages. J. Infect. Dis. 192:149–155.PubMedCrossRef
25.
go back to reference Fernando, S. L., B. M. Saunders, R. Sluyter, K. K. Skarratt, H. Goldberg, G. B. Marks, J. S. Wiley, and W. J. Britton. 2007. A polymorphism in the P2X7 gene increases susceptibility to extrapulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 175:360–366.PubMedCrossRef Fernando, S. L., B. M. Saunders, R. Sluyter, K. K. Skarratt, H. Goldberg, G. B. Marks, J. S. Wiley, and W. J. Britton. 2007. A polymorphism in the P2X7 gene increases susceptibility to extrapulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 175:360–366.PubMedCrossRef
26.
go back to reference Perregaux, D. G., and C. A. Gabel. 1994. Interleukin-1β maturation and release in response to ATP and nigericin: evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J. Biol. Chem. 269:15195–15203.PubMed Perregaux, D. G., and C. A. Gabel. 1994. Interleukin-1β maturation and release in response to ATP and nigericin: evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J. Biol. Chem. 269:15195–15203.PubMed
27.
go back to reference Perregaux, D. G., and C. A. Gabel. 1998. Human monocytes stimulus-coupled IL-1β posttranslational processing: Modulation via monovalent cations. Am. J. Physiol. 275:C1538–C1547.PubMed Perregaux, D. G., and C. A. Gabel. 1998. Human monocytes stimulus-coupled IL-1β posttranslational processing: Modulation via monovalent cations. Am. J. Physiol. 275:C1538–C1547.PubMed
28.
go back to reference Blanchard, D. K., S. McMillen, and J. Y. Djeu. 1991. IFN-gamma enhance sensitivity of human macrophages to extracellular ATP-mediated lysis. J. Immunol. 147:2579–2585.PubMed Blanchard, D. K., S. McMillen, and J. Y. Djeu. 1991. IFN-gamma enhance sensitivity of human macrophages to extracellular ATP-mediated lysis. J. Immunol. 147:2579–2585.PubMed
29.
go back to reference Turner, C. M., F. W. Tam, P. C. Lai, R. M. Tarzi, G. Burnstock, C. D. Pusey, H. T. Cook, and R. J. Unwin. 2007. Increased expression of the pro-apoptotic ATP-sensitive P2X7 receptor in -experimental and human glomerulonephritis. Nephrol. Dial. Transplant. 22:386–395.PubMedCrossRef Turner, C. M., F. W. Tam, P. C. Lai, R. M. Tarzi, G. Burnstock, C. D. Pusey, H. T. Cook, and R. J. Unwin. 2007. Increased expression of the pro-apoptotic ATP-sensitive P2X7 receptor in -experimental and human glomerulonephritis. Nephrol. Dial. Transplant. 22:386–395.PubMedCrossRef
30.
go back to reference Feng, Y. H., L. Wang, Q. Wang, X. Li, R. Zeng, and G. I. Gorodeski. 2005. ATP stimulates GRK-3 phosphorylation and beta-arrestin-2-dependent internalization of P2X7 receptor. Am. J. Physiol. Cell. Physiol. 288:C1342–C1356.PubMedCrossRef Feng, Y. H., L. Wang, Q. Wang, X. Li, R. Zeng, and G. I. Gorodeski. 2005. ATP stimulates GRK-3 phosphorylation and beta-arrestin-2-dependent internalization of P2X7 receptor. Am. J. Physiol. Cell. Physiol. 288:C1342–C1356.PubMedCrossRef
Metadata
Title
A Comparative Study of Interleukin-1β Production and P2x7 Expression After Atp Stimulation by Peripheral Blood Mononuclear Cells Isolated From Rheumatoid Arthritis Patients and Normal Healthy Controls
Authors
Ahmed Al-Shukaili
Juma Al-Kaabi
Batool Hassan
Publication date
01-04-2008
Publisher
Springer US
Published in
Inflammation / Issue 2/2008
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-007-9052-0

Other articles of this Issue 2/2008

Inflammation 2/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.